Woman healthcare: global market trend discussion of infertility, are you ready?

• Infertility’s etiology analysis, diagnosis and prevention & control measures
• Guideline review for infertility treatment in China
• Worldwide research progress & breakthroughs in infertility treatment
• Guest speaker: Treatment & Guideline review for infertility treatment in Europe

Event details

DATE Tuesday, July 26, 2022 VENUE Online Webex / Zoom TIME 10:00 – 11:00 Berlin time (CET) 16:00 – 17:00 Beijing time (GMT+8) RSVP This is a complimentary event VIP tickets priority for Lingmed current clients Please RSVP by July 25, 2022

PRESENTERS Lingling Cao, CEO & Founder Dr Hank Wang, Medical advisor Guest speaker REGISTER +86 21 5386 3003 BD@lingmed.net

Agenda

CET 10:00 - 10:30	Reports on global innovative treatments for infertility	by Dr Hank Wang  (Chinese)
CET 10:30 - 10:35	Linkedbio services & projects introduction	by Lingling Cao  (English)
CET 10:35 - 10:55	Guest speaker: Treatment & Guideline review for infertility treatment in Europe	by Guest speaker   (English)
CET 10:55 – 11:00	Q&A	(English & Chinese)

Presenters

Hank Wang Medical advisor Dr Wang holds a PhD degree on Medicinal Chemistry from Peking University, has a Postdoc experience in University of Missouri-Saint Louis, and worked as a Postdoc Fellow in Auburn University. Hank Wang has more than 20 years’ experience in pharmaceuticals industry. Hank has worked as Vice President and President of R&D at Beijing Haiyan Pharmaceutical Co., Ltd. - Yangtze River Pharmaceutical Group. Dr Wang advises Lingmed on innovative assets evaluation for China market

Lingling Cao CEO & Founder Lingling has more than a decade of experience in the healthcare industry, especially in deal-making. She founded Lingmed, which aims to support BD professionals to make better decisions with intelligence databases and EU-China cross-border deals. Prior to her venture at Lingmed, she was a senior BD manager for Eli Lilly in Shanghai and a consultant for McKinsey in Germany